Clinical trials
Sepsis trials with no applicable phase and unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
95 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 3 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 3 |
| 2014 | 5 |
| 2015 | 3 |
| 2016 | 4 |
| 2017 | 7 |
| 2018 | 9 |
| 2019 | 8 |
| 2020 | 10 |
| 2021 | 16 |
| 2022 | 6 |
| 2023 | 8 |
| 2024 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 95 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Tianjin Nankai Hospital | 3 |
| Iuliu Hatieganu University of Medicine and Pharmacy | 2 |
| National Research Center for Cardiac Surgery, Kazakhstan | 2 |
| Peking Union Medical College Hospital | 2 |
| Phramongkutklao College of Medicine and Hospital | 2 |
| Queen Fabiola Children's University Hospital | 2 |
| Ruijin Hospital | 2 |
| Shanghai 10th People's Hospital | 2 |
| Shanghai Zhongshan Hospital | 2 |
| University of British Columbia | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sepsis | 95 |
| Shock, Septic | 22 |
| Critical Illness | 7 |
| Infections | 7 |
| Acute Kidney Injury | 5 |
| Respiratory Distress Syndrome | 5 |
| Multiple Organ Failure | 4 |
| Bacteremia | 3 |
| Pneumonia | 3 |
| Respiratory Insufficiency | 3 |
Trials
Showing 1 to 25 of 95. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.